Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis

doi:10.3748/wjg.v12.i10.1607

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3123)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

347

HTML

2508

Figures (1-1)

147

Tables (1-4)

121

Sum=3123

Mar 14, 2006 (publication date) through May 10, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Mar 14, 2006; 12(10): 1607-1612
Published online Mar 14, 2006. doi: 10.3748/wjg.v12.i10.1607

Table 1 Laboratory characteristics of patients investigated according to the stage of disease¹

Stage	I	II	III	IV
Patients (n°)	12	11	15	13
Alkaline phosphatase (U/L	273 (50-797)	447 (145-1315)	397 (190-1956)	289 (52-1960)
AST (U/L)	28 (13-6)	38 (25-400)	35 (14-63)	49 (11-144)
ALT (U/L)	37 (14-89)	54 (17-100)	39 (17-72)	47 (8-218)
Total Bilirubin (mg/dL)	0.7 (0.4-2.4)	0.9 (0.2-1.2)	0.9 (0.3-1.5)	1.0 (0.5-1.6)
Cholesterol (mg/dL)	190 (112-235)	220 (104-285)	219 (110-275)	208 (154-314)
aPTT (sec)	32 (27-63)	28 (26-43)	32 (25-37)	32 (26-36)
PT (%)	98 (90-105)	100 (91-120)	99 (81-100)	93 (58-100)
Fibrinogen (mg/dL)	379 (279-650)	380 (268-463)	327 (276-590)	380 (100-586)

¹Data are expressed as median (range).

Table 2 Platelet and blood coagulation tests

	PBC patients n = 51	Controls n = 102
Sonoclot RATE (U/min) all pts	29 (14-49)^b	21 (14-31)
• <150 x 10³/μL plts (n = 22)	30 (14-49)^b
•≥150 x 10³/μL plts (n = 29)	28 (19-41)^d
Sonoclot TP (min) all pts	12 (6-30)^d	9 (6-15)
• <150 x 10³/μL plts (n = 22)	15 (6-30)^d
•≥150 x 10³/μL plts (n = 29)	10 (6-24)
PFA/EPI - CT (secs)	151.5 (60-222)	146 (111-179)
[≥150 x 10³/μL plts (n = 29)]
PFA/ADP- CT (secs)	106 (61-180)	102 (61-148)
[≥150 x 10³/μL plts (n = 29)]
TAT (μg/L)	2.8 (1.5-87.3)^b	2.5 (1.1-4.2)
D-Dimer (ng/mL)	16.0 (2-173)	23.0 (3-55)
TF (pg/mL)	255.6 (24.8-466.1)^d	121.9 (24.8-466.1)
TM (μg/mL)	23.7 (2.6-153.5)^d	13.8 (7.6-23.1)

^bP < 0.01,

^dP < 0.001 vs Controls; TP = time to peak; PFA/EPI - CT = closure time with epinephrine; PFA/ADP-CT = closure time with ADP. Data are expressed as median (range).

Table 3 Homocysteine and vitamin levels in PBC patients and controls

	PBC Patients (n = 51)	Controls (n =102)
Fasting HCY (μmol/L)	12.1 (1.8-58.8)^b	9.9 (6.4-18.0)
Post-methionine HCY (μmol/L)	30.1 (9.2-99.6)^b	28.0(16.4-38.9)
Folic Acid (ng/mL)	5.3(1.2-13.4)^b	10.7(5.4-18.5)
Vitamin B12 (pg/mL	335 (201-977)^a	304.9(176-427.1)
Vitamin B6 (pg/mL)	6.6 (1-20)^b	10.0 (3-17)

^aP < 0.05 vs controls;

^bP < 0.001 vs control.

Table 4 TTMTHFR polymorphism and vitamin state in 51 PBC patients n (%)

MMTHFR	Low folate,normal HCY	Normal folate,high HCY	Low folate,high HCY	Normal folate,normal HCY	Total Nopatients
CT	8 (38)	0	10 (47.6)	3 (14.45)	21
CC	8 (57)	0	2 (14.5)	4 (28.5)	14
TT	3 (18.7)	2 (12.5)	9 (56)	2 (12.5)	16
Total	19	2	21	9

Citation: Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J Gastroenterol 2006; 12(10): 1607-1612
URL: https://www.wjgnet.com/1007-9327/full/v12/i10/1607.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i10.1607